FDA Brief

Warning letters Drugs

FDA warning letter to

rx2go.com

High riskIssued Jan 28, 2021Posted Feb 2, 2021Center for Drug Evaluation and Research | CDER

FDA warned rx2go.com for selling unapproved, misbranded hydroxychloroquine and other drugs online with COVID-19 claims.

What happened

FDA reviewed www.rx2go.com on January 5, 2021, and found that the website offered drug products for sale in the U.S. with claims to treat, prevent, or cure COVID-19 and other diseases. The letter cites hydroxychloroquine marketed as “hydroxychloroquine sulfate (Generic Plaquenil)” and “Signaquine-200” manufactured by Signature, and says no approved applications are in effect for those products. It also says the site misleadingly described the products as FDA-approved and that hydroxychloroquine is not approved for COVID-19.

What FDA found

  1. Offering unapproved new drugs for sale without FDA approval.

    section 505(a) of the FD&C Act [21 U.S.C. § 355(a)]
  2. Selling prescription drugs without adequate directions for use, making them misbranded.

    section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]
  3. Putting unapproved and misbranded drugs into interstate commerce.

    sections 301(a) and (d) of the FD&C Act [21 U.S.C. § 331(a) and (d)]
  4. Calling the hydroxychloroquine products FDA-approved when FDA has not approved those specific products.

    section 502 of the FD&C Act [21 U.S.C. § 352]
  5. Claiming hydroxychloroquine can treat or prevent COVID-19 even though FDA has not approved it for that use.

    section 505(a) of the FD&C Act [21 U.S.C. § 355(a)]

What FDA wants

Within 48 hours, email FDA describing specific steps taken to address the violations and prevent recurrence, with supporting documents. If the company believes it is not violating the law, it must send its reasoning and supporting information within 48 hours.

Who should pay attention

  • consumers who buy prescription drugs from online pharmacies
  • online pharmacies and websites selling COVID-19-related drugs
  • companies whose products are copied or misrepresented as FDA-approved

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk